Topological role of cytochrome P450 2D6 active site residues

被引:9
|
作者
van Waterschoot, RAB
Keizers, PHJ
de Graaf, C
Vermeulen, NPE
Tschirret-Guth, RA [1 ]
机构
[1] Merck Res Labs, Dept Drug Metab, Rahway, NJ 07065 USA
[2] Vrije Univ Amsterdam, LACDR, Div Mol Toxicol, Dept Pharmacochem, NL-1081 HV Amsterdam, Netherlands
关键词
cytochrome p450 2D6; active site topology; aryldiazenes; mutagenesis; molecular modeling;
D O I
10.1016/j.abb.2006.01.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent reports have identified Phe120, Asp301, Thr309, and Glu216 as important residues in cytochrome P450 2D6 (CYP2D6) substrate binding and catalysis. Complementary homology models have located these amino acids within the binding pocket of CYP2D6 and in the present study we have used aryldiazenes to test these models and gain further insight in the role these amino acids have in maintaining the integrity of the active site cavity. When Phe120 was replaced to alanine, there was a significant increase in probe migration to pyrrole nitrogens C and D, in agreement with homology models which have located the phenyl side-chain of Phe120 above these two pyrrole rings. No changes in topology were observed with the D301Q mutant, supporting claims that in this mutant the electrostatic interactions with the B/C-loop are largely maintained and the loop retains its native orientation. The T309V Mutation resulted in significant topological alteration suggesting that, in addition to its potential role in dioxygen activation, Thr309 plays an important structural role within the active site crevice. Replacement of Ile106 with Glu, engineered to cause electrostatic repulsion with Glu216, had a profound topological effect in the higher region within the active site cavity and impaired the catalytic activity towards CYP2D6 probe substrates. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 50 条
  • [31] A refilled substrate model for human cytochrome P450 2D6
    deGroot, MJ
    Bijloo, GJ
    Martens, BJ
    vanAcker, FAA
    Vermeulen, NPE
    CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (01) : 41 - 48
  • [32] Prediction of drug metabolism: The case of cytochrome P450 2D6
    Vermeulen, NPE
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (11) : 1227 - 1239
  • [33] Metabolic Activation of Atomoxetine Mediated by Cytochrome P450 2D6
    You, Yutong
    Wang, Xu
    Ma, Kaiqi
    Li, Jiaru
    Peng, Ying
    Zheng, Jiang
    CHEMICAL RESEARCH IN TOXICOLOGY, 2021, 34 (09) : 2135 - 2144
  • [34] Rapid and reliable method for cytochrome P450 2D6 genotyping
    Stamer, UM
    Bayerer, B
    Wolf, S
    Hoeft, A
    Stüber, F
    CLINICAL CHEMISTRY, 2002, 48 (09) : 1412 - 1417
  • [35] Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen
    Dong, HJ
    Haining, RL
    Thummel, KE
    Rettie, AE
    Nelson, SD
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (12) : 1397 - 1400
  • [36] SUBSTRATE SPECIFICITY OF CYTOCHROME P450 2D6 GENETIC VARIANTS
    van der Lee, M.
    Guchelaar, H.
    Swen, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S9 - S9
  • [37] Cytochrome P450 2D6 genotype variation and venlafaxine dosage
    McAlpine, Donald E.
    O'Kane, Dennis J.
    Black, John L.
    Mrazek, David A.
    MAYO CLINIC PROCEEDINGS, 2007, 82 (09) : 1065 - 1068
  • [38] Treatment of codeine dependence with inhibitors of cytochrome P450 2D6
    Fernandes, LC
    Kilicarslan, T
    Kaplan, HL
    Tyndale, RF
    Sellers, EM
    Romach, MK
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (03) : 326 - 329
  • [39] Effect of Desvenlafaxine on the Cytochrome P450 2D6 Enzyme System
    Preskorn, Sheldon H.
    Nichols, Alice I.
    Paul, Jeffrey
    Patroneva, Albena L.
    Helzner, Eileen C.
    Guico-Pabia, Christine J.
    JOURNAL OF PSYCHIATRIC PRACTICE, 2008, 14 (06) : 368 - 378
  • [40] Coumarin substrates for cytochrome P450 2D6 fluorescence assays
    Nakamura, K
    Hanna, IH
    Cai, HL
    Nishimura, Y
    Williams, KM
    Guengerich, FP
    ANALYTICAL BIOCHEMISTRY, 2001, 292 (02) : 280 - 286